Ng Shu-Hang, Chan Sheng-Chieh, Yen Tzu-Chen, Chang Joseph Tung-Chieh, Liao Chun-Ta, Ko Sheung-Fat, Liu Feng-Yuan, Chin Shu-Chyn, Fan Kang-Hsing, Hsu Cheng-Lung
Molecular Imaging Center and Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Chang Gung University, Kueishan, Taiwan.
Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):12-22. doi: 10.1007/s00259-008-0918-7. Epub 2008 Aug 15.
We prospectively compared PET/CT and conventional imaging for initial staging of nasopharyngeal carcinoma (NPC).
A total of 111 patients with histologically proven NPC were investigated with PET/CT and conventional imaging (head-and-neck MRI, chest X-ray, abdominal ultrasound, and bone scan) before treatment. The respective findings were reviewed independently and then compared with each other.
With regard to T staging, PET/CT showed a discrepancy with head-and-neck MRI in 36 (32.4%) of the study subjects. With regard to N staging, PET/CT showed a discrepancy with head-and-neck MRI in 15 (13.5%) patients. Among the discordant cases, MRI was superior in demonstrating tumor involvement in the parapharyngeal space, skull base, intracranial area, sphenoid sinus, and retropharyngeal nodes while PET/CT was superior in demonstrating neck nodal metastasis. PET/CT disclosed 13 of 16 patients with distant malignancy compared with four patients disclosed by conventional imaging work-up. The false-positive rate of PET/CT was 18.8%. PET/CT correctly modified M staging in eight patients (7.2%) and disclosed a second primary lung malignancy in one patient (0.9%).
In NPC patients, MRI appears to be superior to PET/CT for the assessment of locoregional invasion and retropharyngeal nodal metastasis. PET/CT is more accurate than MRI for determining cervical nodal metastasis and should be the better reference for the neck status. PET/CT has an acceptable diagnostic yield and a low false-positive rate for the detection of distant malignancy and can replace conventional work-up to this aim. PET/CT and head-and-neck MRI are suggested for the initial staging of NPC patients.
我们前瞻性地比较了PET/CT与传统成像技术在鼻咽癌(NPC)初始分期中的应用。
对111例经组织学证实的NPC患者在治疗前进行了PET/CT及传统成像检查(头颈部MRI、胸部X线、腹部超声和骨扫描)。分别独立审查各自的检查结果,然后相互比较。
在T分期方面,PET/CT与头颈部MRI在36例(32.4%)研究对象中显示存在差异。在N分期方面,PET/CT与头颈部MRI在15例(13.5%)患者中显示存在差异。在不一致的病例中,MRI在显示咽旁间隙、颅底、颅内区域、蝶窦和咽后淋巴结的肿瘤累及方面更具优势,而PET/CT在显示颈部淋巴结转移方面更具优势。PET/CT发现了16例远处恶性肿瘤患者中的13例,而传统成像检查发现了4例。PET/CT的假阳性率为18.8%。PET/CT正确修正了8例患者(7.2%)的M分期,并发现1例患者(0.9%)存在第二原发性肺癌。
在NPC患者中,MRI在评估局部区域侵犯和咽后淋巴结转移方面似乎优于PET/CT。PET/CT在确定颈部淋巴结转移方面比MRI更准确,应为颈部情况的更好参考。PET/CT在检测远处恶性肿瘤方面具有可接受的诊断率和较低的假阳性率,可为此目的替代传统检查。建议对NPC患者进行PET/CT和头颈部MRI检查以进行初始分期。